1-7 of 7
Arijit Sinha
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: A Phase 2 Study of Linvoseltamab for the Treatment of High-Risk Smoldering Multiple Myeloma (LINKER-SMM1)

Paula Rodriguez Otero, Maria-Victoria Mateos, Oluwaseun Aina, Arijit Sinha, Andrew J Steele, Anasuya Hazra, Karen Rodriguez Lorenc, Glenn S. Kroog, Shawn M Sarkaria, Jesus San Miguel
Journal: Blood
Blood (2023) 142 (Supplement 1): 3393.
https://doi.org/10.1182/blood-2023-179356
Published: 2023
Journal Articles

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Franck Morschhauser, Pierre Feugier, Ian W. Flinn, Robin Gasiorowski, Richard Greil, Árpád Illés, Nathalie A. Johnson, Jean-François Larouche, Pieternella J. Lugtenburg, Caterina Patti, Gilles A. Salles, Marek Trněný, Sven de Vos, Farheen Mir, Divya Samineni, Su Y. Kim, Yanwen Jiang, Elizabeth Punnoose, Arijit Sinha, Emma Clark, Nathalie Spielewoy, Kathryn Humphrey, Alexandra Bazeos, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 137 (5): 600–609.
https://doi.org/10.1182/blood.2020006578
Published: 2021
Includes: Supplemental data
Journal Articles

Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma

Clinical Trials & Observations
Pier Luigi Zinzani, Ian W. Flinn, Sam L. S. Yuen, Max S. Topp, Chiara Rusconi, Isabelle Fleury, Katell Le Dû, Christopher Arthur, Barbara Pro, Giuseppe Gritti, Michael Crump, Adam Petrich, Divya Samineni, Arijit Sinha, Elizabeth A. Punnoose, Edith Szafer-Glusman, Nathalie Spielewoy, Mehrdad Mobasher, Kathryn Humphrey, Martin Kornacker, Wolfgang Hiddemann
Journal: Blood
Blood (2020) 136 (23): 2628–2637.
https://doi.org/10.1182/blood.2020005588
Published: 2020
Includes: Supplemental data
Journal Articles

Prevention and Management of Tumor Lysis Syndrome in Patients with CLL and Coexisting Conditions Treated with Venetoclax-Obinutuzumab or Chlorambucil-Obinutuzumab: Results from the Randomized CLL14 Trial

Othman Al-Sawaf, MD, Anna-Maria Fink, MD, Sandra Robrecht, PhD, Arijit Sinha, PhD, Maneesh Tandon, MD, Barbara F. Eichhorst, MD, Kirsten Fischer, MD, Michael Hallek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4315.
https://doi.org/10.1182/blood-2019-126570
Published: 2019
Journal Articles

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

Clinical Trials & Observations
Andrew D. Zelenetz, Gilles Salles, Kylie D. Mason, Carla Casulo, Steven Le Gouill, Laurie H. Sehn, Herve Tilly, Guillaume Cartron, Martine E. D. Chamuleau, Andre Goy, Constantine S. Tam, Pieternella J. Lugtenburg, Adam M. Petrich, Arijit Sinha, Divya Samineni, Sylvia Herter, Ellen Ingalla, Edith Szafer-Glusman, Christian Klein, Deepak Sampath, Martin Kornacker, Mehrdad Mobasher, Franck Morschhauser
Journal: Blood
Blood (2019) 133 (18): 1964–1976.
https://doi.org/10.1182/blood-2018-11-880526
Published: 2019
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Venetoclax (Ven) + Rituximab (R) or Ven + Bendamustine (B) + R Randomized Versus B + R in Patients (pts) with Relapsed/Refractory (R/R) Follicular Lymphoma (FL): Final Analysis of Phase II CONTRALTO Study

Pier Luigi Zinzani, MD, Ian W. Flinn, MD PhD, Sam Yuen, Max S. Topp, Chiara Rusconi, Isabelle Fleury, Christopher K Arthur, Barbara Pro, MD, Giuseppe Gritti, MD PhD, Michael Crump, Katell Le Du, MD, Divya Samineni, Arijit Sinha, Elizabeth A Punnoose, Edith Szafer-Glusman, Nathalie Danesi, Adam Petrich, Martin Kornacker, Kathryn Humphrey, Mehrdad Mobasher, MD MPH, Wolfgang Hiddemann
Journal: Blood
Blood (2018) 132 (Supplement 1): 1614.
https://doi.org/10.1182/blood-2018-99-116806
Published: 2018
Journal Articles

Venetoclax Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) Improves Outcomes in BCL2-Positive First-Line Diffuse Large B-Cell Lymphoma (DLBCL): First Safety, Efficacy and Biomarker Analyses from the Phase II CAVALLI Study

Franck Morschhauser, Pierre Feugier, Ian W. Flinn, MD PhD, Robin E Gasiorowski, Richard Greil, MD, Árpád Illés, Nathalie A Johnson, MDPhD, Jean-Francois Larouche, Pieternella J Lugtenburg, Caterina Patti, Gilles Salles, MD PhD, Marek Trněný, Sven de Vos, Farheen Mir, MBBS, Martin Kornacker, Elizabeth A Punnoose, Divya Samineni, Edith Szafer-Glusman, Adam Petrich, Arijit Sinha, Mehrdad Mobasher, MD MPH, Andrew D. Zelenetz, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 782.
https://doi.org/10.1182/blood-2018-99-118519
Published: 2018